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Purpose: Acute pancreatitis is one of the potentially lethal complications that oc-
curs after cardiac surgery. We tried to identify risk factors for and the prognosis of 
acute pancreatitis after cardiac valve surgery with cardiopulmonary bypass. Mate-
rials and Methods: We retrospectively analyzed a database of consecutive pa-
tients who underwent cardiac valve surgery with cardiopulmonary bypass between 
January 2005 and April 2010 at our institution. Patients were classified as having 
acute pancreatitis based on serum lipase concentration and clinical symptoms (li-
pase ≥180 U/L or ≥60 U/L with relevant symptoms). Results: Of the 986 patients 
who underwent cardiac valve surgery with cardiopulmonary bypass, 58 (5.9%) pa-
tients developed post-operative pancreatitis. Post-operative hospital stay was sig-
nificantly longer (29.7±45.6 days vs. 12.4±10.7 days, p=0.005) and in-hospital 
mortality rate was higher (15.5% vs. 2.0%, p<0.001) in patients with post-opera-
tive pancreatitis than those without. Hypertension, chronic kidney disease, and 
peri-operative use of norepinephrine were identified as independent risk factors for 
developing pancreatitis after cardiac valve surgery. Conclusion: We found that 
acute pancreatitis after cardiac valve surgery requires longer hospitalization and in-
creases the in-hospital mortality rate. Clinicians should be aware that patients 
could develop pancreatitis after cardiac valve surgery, especially in patients with 
hypertension and chronic kidney disease treated with norepinephrine.
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INTRODUCTION
Gastrointestinal complications after cardiovascular surgery are important for the 
prognosis of patients.1-6 However, the management of gastrointestinal complica-
tions is often difficult, and mortality can occur in severe cases. The most common 
complications are gastroduodenal ulcers, enterocolitis, and ischemic colitis. To 
manage these complications, procedures such as endoscopy or transfusion may be 
needed, and longer post-operative hospital stays and higher costs can be incurred. 
In order to prevent gastrointestinal complications and decrease their associated 
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ylase and lipase concentrations on post-operative day 2, du-
ration of CPB, presence of post-operative complications, 
post-operative hospital stay, and in-hospital mortality. The 
diagnostic criteria for post-operative pancreatitis was an el-
evated serum lipase concentration (≥180 U/L) three-fold 
greater than the upper limit of normal concentration, or the 
presence of relevant symptoms and/or signs (abdominal 
pain, abdominal distention, nausea, vomiting and ileus) to-
gether with serum lipase concentration greater than the up-
per limit of normal concentration (≥60 U/L) on the second 
day after surgery.16 When post-operative pancreatitis was 
diagnosed, patients were conservatively treated with bowel 
rest and/or proteinase inhibitor according to the severity. 
The Institutional Review Board of Severance Hospital, 
Yonsei University approved this retrospective study.
Statistical analysis
Continuous variables are presented as mean±standard devi-
ation and were compared using the Wilcoxon rank-sum 
test. Intergroup comparisons of categorical variables were 
performed by Pearson χ2 test or Fisher’s exact test. To iden-
tify independent factors associated with the development of 
post-operative pancreatitis, explanatory items were selected 
using univariate analysis, followed by multivariate logistic 
regression analysis. We applied a backward stepwise selec-
tion procedure beginning with variables that exhibited a p 
value less than 0.05 in univariate analysis. Adjusted odds 
ratios (AOR) were calculated to measure the degree of as-
sociations, and Hosmer-Lemeshow goodness-of-fit analy-
ses were used to calibrate multivariate logistic regression. 
We considered p values less than 0.05 as statistically signif-
icant and all statistical tests were 2-sided. Statistical analy-
ses were performed using SPSS 18.0 for Windows (SPSS 
Inc., Chicago, IL, USA). 
 
RESULTS
 
Patient characteristics and clinical data
A total 986 consecutive patients, 460 males (46.7%) and 
526 females (53.3%), underwent cardiac valve surgery with 
CPB during the study period, and their mean age was 
56.9±14.8 years. Two-thirds of the patients (669 patients) 
underwent single valve surgery, and one-third (317 pa-
tients) underwent double valve surgery. The post-operative 
hospital stay was 13.4±15.6 days and the in-hospital mor-
tality rate was 2.8% (28 of 986 patients). 
morbidity and mortality, there have been many studies re-
garding their incidence, risk factors, and management.
Acute pancreatitis is an inflammatory disorder with a vari-
ety of etiologies, including obstruction (gallstone, malignan-
cy, surgery, and endoscopic retrograde cholangiopancreatog-
raphy), vascular insufficiency, and toxic agents (alcohol, 
azathioprine, etc.). The widespread pathophysiological 
mechanisms are involved in the inflammatory process and 
lead to a variety of systemic complications.7 There is no ef-
fective way to manage acute pancreatitis except conserva-
tive treatment, and the outcome depends on its severity and 
the presence of organ failure. Therefore, it has been empha-
sized for many years to predict disease severity at an early 
stage and to apply intense treatment in severe cases.7
After cardiac surgery, acute pancreatitis is a potentially 
fatal complication leading to high mortality.1,2,6,8,9 While the 
significance is well recognized, several of its indicators re-
main controversial. The incidence of acute pancreatitis var-
ies depending on the type of surgery and diagnostic criteria, 
ranging from 0.05% to 19%.5,6,8-12 Additionally, asymptom-
atic hyperamylasemia is more frequently seen in 24% to 
85% of patients after cardiac surgery.10,11,13-15 Even all pa-
tients do not progress to symptomatic pancreatitis, hyper-
amylasemia alone may be associated with higher post-oper-
ative mortality.10,11 However, we do not know much about 
what is important in the development of symptomatic or as-
ymptomatic pancreatitis and how they affect the clinical 
outcomes of cardiac surgery.
Therefore, we evaluated the incidence, risk factors, and 
clinical implications of acute pancreatitis after cardiac valve 
surgery with cardiopulmonary bypass (CPB) at our institu-
tion.
MATERIALS AND METHODS
　　　
Patient sample and data collection
We retrospectively analyzed the database of all patients who 
underwent cardiac valve surgery with CPB between January 
2005 and April 2010 at Severance Hospital, Yonsei Univer-
sity College of Medicine, Seoul, Korea. Demographic, clini-
cal, and laboratory data were collected from medical re-
cords that were documented at the time of treatment. These 
data included gender, age, co-morbidities (hypertension, di-
abetes mellitus, and chronic kidney disease), drug history, 
smoking history, pre-operative ejection fraction by echocar-
diography, peri-operative use of norepinephrine, serum am-
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12.9%) than those without post-operative pancreatitis 
(60.6±12.2%), but the difference was not statistically signif-
icant (p=0.116). Patients with post-operative pancreatitis 
were more frequently treated with norepinephrine during 
peri-operative period (70.7% vs. 26.1%, p<0.001). The se-
rum amylase was 523.9±470.1 U/L in patients with post-
operative pancreatitis and 224.8±308.1 U/L in those with-
out post-operative pancreatitis (p<0.001).
Patients with post-operative pancreatitis had a longer post-
operative hospital stay (29.7±45.6 days vs. 12.4±10.7 days, 
p=0.005) and a higher in-hospital mortality rate (15.5% vs. 
2.0%; p<0.001) than those without post-operative pancre-
atitis. The odds ratio of in-hospital mortality being associat-
ed with post-operative pancreatitis was 8.787 [95% confi-
dence interval (CI); 3.780-20.428]. Table 1 summarizes the 
patients’ clinical data and outcomes of cardiac valve surgery. 
Risk factors for post-operative pancreatitis after 
cardiac valve surgery with CPB
Univariate regression analyses indicated that hypertension 
(p<0.001), chronic kidney disease (p<0.001), and the use of 
norepinephrine (p<0.001) were significantly associated with 
post-operative pancreatitis. According to multivariate re-
gression analysis, hypertension (AOR=2.263, 95% CI; 
1.290-3.969), chronic kidney disease (AOR=2.653, 95% CI; 
1.080-6.516), and the use of norepinephrine (AOR=6.047, 
95% CI; 3.334-10.968) were identified as independent risk 
Fulfilling the above-mentioned criteria in the methods 
section, 58 patients (5.9%) were diagnosed with post-oper-
ative pancreatitis, of whom 27 patients developed isolated 
hyperlipasemia and 31 patients developed symptomatic hy-
perlipasemia. Alcohol or drug induced pancreatitis was 
ruled out by preoperative history taking, and acute pancre-
atitis by gallstone or pancreatic neoplasm was not identified 
during the follow-up period in these patients. The most 
common symptoms in these patients were abdominal pain 
(16 of 58 patients, 27.6%) and nausea and vomiting (13 of 
58 patients, 22.4%), followed by fever (11 of 58 patients, 
19.0%). Pleural effusion was the most common accompa-
nying complication (17 of 58 patients, 29.3%), followed by 
acute renal failure (15 of 58 patients, 25.9%), infection (11 
of 58 patients, 19.0%) and upper gastrointestinal bleeding 
(6 of 58 patients, 10.3%). 
Comparisons of clinical factors and outcomes with the 
development of post-operative pancreatitis
Comparative analysis of clinical data on the development of 
post-operative pancreatitis revealed that there is no signifi-
cant difference in age, gender, history of diabetes, smoking 
history, type of surgery, or mean CPB time. Hypertension 
(46.6% vs. 24.8%) and chronic kidney disease (13.8% vs. 
2.7%) were more common in patients with post-operative 
pancreatitis (p<0.001). Preoperative ejection fraction was 
lower in patients with post-operative pancreatitis (58.0± 
Table 1. Patient Characteristics and Clinical Data
Patient without post-operative 
pancreatitis (n=928, 94.1%)
Patient with post-operative 
pancreatitis (n=58, 5.9%)
p value
Male, n (%) 434 (46.8) 26 (44.8)   0.774
Age at operation, yrs   56.9±14.8   57.6±15.7   0.747
Comorbidity, n (%)
    Diabetes mellitus 110 (11.9) 10 (17.2)   0.223
    Hypertension 230 (24.8) 27 (46.6) <0.001
    Chronic kidney disease 25 (2.7)   8 (13.8) <0.001
    Smoking history 127 (13.7) 5 (8.6)   0.272
Peri-operative factor
    Pre-operative ejection fraction, %   60.6±12.2   58.0±12.9   0.116
    Single/Double valve operation, n (%) 627 (67.6)/301 (32.4) 42 (72.4)/16 (27.6)   0.443
    Cardiopulmonary bypass time, min 132.0±50.7 138.9±52.8   0.315
    Use of norepinephrine, n (%) 242 (26.1) 41 (70.7) <0.001
Post-operative outcome
    Lipase, U/L*   24.9±23.1   546.2±613.4 <0.001
    Amylase, U/L*   224.8±308.1   523.9±470.1 <0.001
    Post-operative hospital stay, days   12.4±10.7   29.7±45.6   0.005
    In-hospital mortality, n (%) 19 (2.0)   9 (15.5) <0.001
*Serum amylase and lipase levels were obtained on the second day after surgery.
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serum marker for diagnosing acute pancreatitis, it is neither 
specific nor sensitive for detecting pancreatic cellular injury 
because post-operative hyperamylasemia may result from 
an increased production of either pancreatic or salivary type 
amylase11,14,15 and decreased clearance of amylase.18 In con-
trast, lipase is a more sensitive and specific biomarker that 
is done as a single laboratory test for acute pancreatitis.16,19-21 
Lipase increased earlier and to a greater extent than total 
amylase, and the peak activities of lipase and pancreatic 
type amylase in the serum have shown significant correla-
tion.14 In addition, serum lipase remains elevated for a lon-
ger period of time than serum amylase.22 When the serum 
lipase level was elevated three times greater than the upper 
limit of normal level, the diagnostic accuracy of acute pan-
creatitis was improved.19
Compared to previous studies, we detected a slightly high-
er incidence of acute pancreatitis after cardiac valve surgery 
(5.9%). Perez, et al.9 reported that acute pancreatitis oc-
curred in 39 of 10249 (0.6%) cardiac surgery cases, and 
other studies reported similar incidences.6,10,11 We may ex-
plain the difference in the incidence as follows. Firstly, the 
diagnostic criteria of acute pancreatitis in other studies were 
more restrictive than those in our study. Perez, et al.9 de-
fined acute pancreatitis as the presence of relevant symp-
toms together with elevated serum amylase and lipase lev-
el. The other studies included serum isoamylase or urine 
amylase to diagnose acute pancreatitis,10,11 and even com-
puted tomography imaging was included to make a diagno-
sis.6,11 At our hospital, we uniformly checked serum amy-
lase and lipase of all patients on the second day of cardiac 
valve surgery and defined the criteria more extensively. We 
defined the criteria in this manner because acute pancreatitis 
may occur without symptoms or elevation of pancreatic en-
zyme8 and asymptomatic pancreatic injury presenting iso-
lated hyperamylasemia or hyperlipasemia can affect clini-
cal outcomes after surgery. Therefore, we were able to 
detect more cases of post-operative pancreatitis including 
even asymptomatic patients.11 Secondly, the incidence of 
gastrointestinal complications differs depending on the type 
of cardiovascular surgery. This study focused on cardiac 
valve surgery, while other studies included various types of 
factors for post-operative pancreatitis (Table 2). The p value 
calculated by the Hosmer-Lemeshow χ2 statistic was 0.389, 
and the model showed no evidence of a lack of fit.
DISCUSSION
We identified that post-operative pancreatitis adversely af-
fected clinical outcomes of cardiac valve surgery by increas-
ing hospital stay and mortality. Previous studies reported 
that splanchnic ischemia during cardiac surgery might cause 
pancreatic cellular injury,8-10,15 and several risk factors have 
also been suggested.8-10 However, there is a lack of data for 
the clinical implications. Patients with acute pancreatitis of-
ten require one or more days of fasting for bowel rest de-
pending on the severity as well as additional time in the 
hospital to evaluate and treat other associated complications 
such as pleural effusion, acute renal failure, infection, gas-
trointestinal bleeding, and acute cholecystitis.9-11 Patients 
with post-operative pancreatitis may take more time to re-
cover from surgery and sometimes do not recover because 
acinar cell injury results from local injury, systemic inflam-
mation, and subsequent multi-organ failure. This implies 
that physicians should carefully monitor these patients for 
the development of acute pancreatitis after surgery. 
Post-operative pancreatitis occurs unpredictably and may 
be difficult to diagnose. According to an autopsy study, the 
diagnosis of pancreatitis was sometimes missed because of 
the absence of pain, tenderness, and hyperamylasemia.8 
Considering isolated hyperamylasemia may have the po-
tential to deteriorate the clinical course of patients and in-
crease the risk of mortality,11 careful attention to pancreatic 
injury should be given in asymptomatic patients, especially 
after cardiac surgery. Due to the diagnosis of acute pancre-
atitis being largely based on clinical presentation with the 
assistance of laboratory findings,17 we assumed that some 
cases of asymptomatic pancreatitis were missed and its in-
fluence on clinical progress might be ignored. To identify 
the existence of postoperative pancreatitis, we checked the 
serum lipase concentration in all patients after cardiac valve 
surgery. Even though amylase is the most commonly used 
Table 2. Multivariate Analysis of Risk Factors for Acute Pancreatitis after Cardiac Valve Surgery
p value Adjusted odds ratio 95.0% CI
Hypertension    0.004 2.263 1.290-3.969
Chronic kidney disease    0.033 2.653 1.080-6.516
The use of norepinephrine <0.001 6.047   3.334-10.968
CI, confidence interval.
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level of amylase and lipase, which meant that the possibility 
that patients already had hyperlipasemia before surgery could 
not be excluded. Furthermore, it was not clearly determined 
whether systemic or local complications that occurred in 
postoperative pancreatitis patients were caused by pancre-
atitis or by other problems. However, these complications 
could be associated with other ischemic causes that might 
have induced acute pancreatitis. Further prospective studies 
are needed to identify the causal relationship between these 
complications and pancreatitis. 
In conclusion, post-operative pancreatitis after cardiac 
valve surgery occurred frequently and affected the clinical 
outcome of patients. Especially, patients with hypertension 
or chronic kidney disease and those who were treated with 
norepinephrine during the peri-operative period were more 
susceptible to pancreatitis. Checking serum lipase is a sim-
ple and reasonable method to detect acute pancreatitis in 
patients after cardiac valve surgery. Therefore, we suggest 
that clinicians assess risk factors for acute pancreatitis be-
fore cardiac valve surgery and remain vigilant for signs and 
symptoms after surgery. Further studies regarding preven-
tion and early management of acute pancreatitis in this set-
ting are warranted. 
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